BMO cuts BioNTech price target to $105 from $128
BMO Capital cut its BioNTech price target to $105.00 per share from $128.00, according to Benzinga ratings actions.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.